BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2850190)

  • 1. In vitro chemical eradication of small cell lung cancer: application in autologous bone marrow transplantation.
    Benard J; Bettan-Renaud L; Gavoille A; Pico JL; Beaujean F; Lopez M; Riou G
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1561-6. PubMed ID: 2850190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
    Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Tamayo E; Hervé P
    Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
    Multon E; Riou JF; LeFevre D; Ahomadegbe JC; Riou G
    Biochem Pharmacol; 1989 Jul; 38(13):2077-86. PubMed ID: 2544183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation in the therapy of small cell carcinoma of the lung.
    Glode LM; Robinson WA; Hartmann DW; Klein JJ; Thomas MR; Morton N
    Cancer Res; 1982 Oct; 42(10):4270-5. PubMed ID: 6286106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.
    Jensen PB; Roed H; Sehested M; Demant EJ; Vindeløv L; Christensen IJ; Hansen HH
    Cancer Chemother Pharmacol; 1992; 31(1):46-52. PubMed ID: 1360876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer.
    Wilson C; Pickering D; Stewart S; Vallis K; Kalofonos H; Cross A; Snook D; Goldman JM; McKenzie CG; Epenetos AA
    In Vivo; 1988; 2(5):331-4. PubMed ID: 2856521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Late intensive chemotherapy with bone marrow autograft. Pilot study in small cell bronchial cancer].
    Sculier JP; Klastersky J; Stryckmans P
    Presse Med; 1983 Mar; 12(11):677-80. PubMed ID: 6300826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High dose chemotherapy with autologous bone marrow rescue for small cell lung cancer].
    Bao YH
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):452-5. PubMed ID: 1315671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of combination drug purging for autologous bone marrow transplantation.
    Jones RJ; Miller CB; Zehnbauer BA; Rowley SD; Colvin OM; Sensenbrenner LL
    Bone Marrow Transplant; 1990 May; 5(5):301-7. PubMed ID: 2350626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
    Miller G; Brashear T; Stone M; Fay J
    Int J Cell Cloning; 1991 Sep; 9(5):503-10. PubMed ID: 1955738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
    Elias AD; Pap SA; Bernal SD
    Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of monoclonal antibodies to diagnosis and treatment of small cell lung cancers].
    Fujisawa M; Okabe T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):984-9. PubMed ID: 2839119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines.
    Kasahara K; Fujiwara Y; Sugimoto Y; Nishio K; Tamura T; Matsuda T; Saijo N
    J Natl Cancer Inst; 1992 Jan; 84(2):113-8. PubMed ID: 1310509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M; Mary JY; Sainteny F
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose etoposide and autologous bone marrow transplantation as intensification treatment in small cell lung cancer: a pilot study.
    Marangolo M; Rosti G; Amadori D; Leoni M; Ardizzone A; Fiorentini G; Cruciani G; Tienghi A; Ravaioli A; Sebastiani L
    Bone Marrow Transplant; 1989 Jul; 4(4):405-8. PubMed ID: 2550104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen gel cultures for detection of spared hematopoietic progenitors in Asta Z 7557 purged human marrows.
    Praloran V; Dobo I; Garand R; Klausman M; Naud MF; Milpied N; Harousseau JL
    Leukemia; 1990 Apr; 4(4):282-6. PubMed ID: 2366583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro chemosensitivity of human lung cancer cell lines.
    Ruckdeschel JC; Carney DN; Oie HK; Russell EK; Gazdar AF
    Cancer Treat Rep; 1987; 71(7-8):697-704. PubMed ID: 3038314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
    Ihde DC; Deisseroth AB; Lichter AS; Bunn PA; Carney DN; Cohen MH; Veach SR; Makuch RW; Johnston-Early A; Abrams RA
    J Clin Oncol; 1986 Oct; 4(10):1443-54. PubMed ID: 3020181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.